«Production of Lentivirus particles pseudotyped with SARS-CoV-2 spike protein for neutralisation or drug antiviral activity assays». 2023. One Health & Risk Management , desember, 77. https://ojs.maxaccs.ie/index.php/journal-ohrm-bba-md/article/view/657.